immunocal clinical studies glutathione Immunocal: Clinically Proven Boost I Immunotec Scientific and Medical Publications Featuring
Description
DG-02 and its potential for bioremediation of pyrethroid-contaminated soils
222 359385 (Academic Press, London, 1993)
It undergoes phase I metabolism via CYP450 and FMO enzymes, and phase II via sulfonation and glucuronidation, producing -monoglucuronides (94, 110, 111)
Intravenous Glutathione products proven and approved use is primarily for medical use ie supportive treatment for chemotherapy patients and NOT for cosmetic purposes
10.1074/jbc.M113.527150 42 CookeK
